Single Phase III Trial Plus Confirmatory Data May Aid NDAs - UCSF's Sheiner
Executive Summary
A single, well-controlled efficacy trial supported by confirmatory evidence may establish pharmacological causality better than traditional trial replication, Lewis Sheiner, MD, University of California-San Francisco, told a Drug Information Association meeting Jan. 22.